Revance Therapeutics (RVNC) January 5 puts active as share price down 16.5%

Revance Therapeutics (NASDAQ: RVNC) 30-day option implied volatility is at 101; compared to its 52-week range of 14 to 134. Call put ratio 1 call to 2.4 puts with focus on January 5 puts as share price down 16.5%.

You May Also Be Interested In

• Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
• Increasing unusual put option volume: IHI HBAN DBX FOXA EYPT CARR FEZ DT NVS ITB HWM TRIP
• Docusign Inc. (DOCU) call put ratio 1 call to 1.3 puts into quarter results